Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $199.33 million. The enterprise value is $59.85 million.
Important Dates
The last earnings date was Monday, March 17, 2025, after market close.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | May 30, 2024 |
Share Statistics
INBX has 14.48 million shares outstanding. The number of shares has increased by 27.17% in one year.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | +27.17% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.02% |
| Owned by Institutions (%) | 49.89% |
| Float | 7.71M |
Valuation Ratios
The trailing PE ratio is 0.12.
| PE Ratio | 0.12 |
| Forward PE | n/a |
| PS Ratio | 1,022.00 |
| Forward PS | n/a |
| PB Ratio | 1.53 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.04 |
| EV / Sales | 299.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.94 |
| Quick Ratio | 3.76 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.52 |
Financial Efficiency
Return on equity (ROE) is 1,905.92% and return on invested capital (ROIC) is -83.29%.
| Return on Equity (ROE) | 1,905.92% |
| Return on Assets (ROA) | -67.37% |
| Return on Invested Capital (ROIC) | -83.29% |
| Return on Capital Employed (ROCE) | -188.08% |
| Revenue Per Employee | $1,242 |
| Profits Per Employee | $10.48M |
| Employee Count | 161 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 34.28 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | 0.00% |
Stock Price Statistics
| Beta (5Y) | 2.88 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 13.37 |
| 200-Day Moving Average | 14.36 |
| Relative Strength Index (RSI) | 54.01 |
| Average Volume (20 Days) | 98,959 |
Short Selling Information
The latest short interest is 955,403, so 6.60% of the outstanding shares have been sold short.
| Short Interest | 955,403 |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 6.60% |
| Short % of Float | 12.39% |
| Short Ratio (days to cover) | 13.81 |
Income Statement
In the last 12 months, INBX had revenue of $200,000 and earned $1.69 billion in profits. Earnings per share was $112.62.
| Revenue | 200,000 |
| Gross Profit | -203.54M |
| Operating Income | -263.39M |
| Pretax Income | n/a |
| Net Income | 1.69B |
| EBITDA | -261.10M |
| EBIT | -263.39M |
| Earnings Per Share (EPS) | $112.62 |
Full Income StatementBalance Sheet
The company has $152.60 million in cash and $8.05 million in debt, giving a net cash position of $144.55 million or $9.99 per share.
| Cash & Cash Equivalents | 152.60M |
| Total Debt | 8.05M |
| Net Cash | 144.55M |
| Net Cash Per Share | $9.99 |
| Equity (Book Value) | 133.58M |
| Book Value Per Share | 9.23 |
| Working Capital | 119.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$194.41 million and capital expenditures -$2.60 million, giving a free cash flow of -$197.01 million.
| Operating Cash Flow | -194.41M |
| Capital Expenditures | -2.60M |
| Free Cash Flow | -197.01M |
| FCF Per Share | -$13.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -131,693.50% |
| Pretax Margin | 843,787.00% |
| Profit Margin | 843,786.00% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |